TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 120-133

  Page, Dawne M ^a   Roberts, Edda M ^a   Peschon, Jacques J ^b   Hedrick, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; DEATH INDUCING PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SELECTION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD3; ANTIGENS, CD30; ANTIGENS, CD40; CELLS, CULTURED; CLONAL DELETION; FEMALE; FLOW CYTOMETRY; H-Y ANTIGEN; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031883138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Nossal, G. J. V. 1994. Negative selection of lymphocytes. Cell 76:229.
2. Jameson, S. C., K. A. Hogquist, and M. J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93.
3. Alam, S. M., P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath, S. C. Jameson, and N. R. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection [see comments]. Nature 381:616.
4. Robey, E., and B. J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675.
5. + thymocytes. Nature 333:742.
6. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.
7. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559.
8. Berg, L. J., B. F. de St. Groth, A. M. Pullen, and M. M. Davis. 1989. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection. Nature 340:559.
9. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
10. Hengartner, H., B. Odermatt, R. Schneider, M. Schreyer, G. Walle, H. R. MacDonald, and R. M. Zinkernagel. 1988. Deletion of self-reactive T cells before entry into the thymus medulla. Nature 336:388.
11. Guidos, C. J., J. S. Danska, C. G. Fathman, and I. L. Weissman. 1990. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J. Exp. Med. 172:835.
12. Vasquez, N. J., J. Kaye, and S. M. Hedrick. 1992. In vivo and in vitro clonal deletion of double-positive thymocytes. J. Exp. Med. 175:1307.
13. Zal, T., A. Volkmann, and B. Stockinger. 1994. Mechanisms of tolerance induction in major histocompatability complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089.
14. Morishima, C., C. Norby-Slycord, K. R. McConnell, R. J. Finch, A. J. Nelson, A. G. Farr, and A. M. Pullen. 1994. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages. J. Immunol. 153:5091.
15. Oehen, S., L. Feng, Y. Xia, C. D. Surh, and S. M. Hedrick. 1996. Antigen compartmentation and T helper cell tolerance induction. J. Exp. Med. 183:2617.
16. Oukka, M., E. Colucci-Guyon, P. L. Tran, M. Cohen-Tannoudji, C. Babinet, V. Lotteau, and K. Kosmatopoulos. 1996. CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 4:545.
17. Kishimoto, H., and J. Sprent. 1997. Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185:263.
18. + thymocytes. J. Immunol. 151: 1868.
19. Aiba, Y., O. Mazda, M. M. Davis, S. Muramatsu, and Y. Katsura. 1994. Requirement of a second signal from antigen presenting cells in the clonal deletion of immature T cells. Int. Immunol. 6:1475.
20. Foy, T. M., D. M. Page, T. J. Waldschmidt, A. Schoneveld, J. D. Laman, S. R. Masters, L. Tygrett, J. A. Ledbetter, A. Aruffo, E. Claassen, J. C. Xu, R. A. Flavell, S. Oehen, S. M. Hedrick, and R. J. Noelle. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377.
21. Amakawa, R., A. Hakem, T. M. Kundig, T. Matsuyama, J. J. Simard, E. Timms, A. Wakeham, H. W. Mittruecker, H. Griesser, H. Takimoto, R. Schmits, A. Shahinian, P. Ohashi, J. M. Penninger, and T. W. Mak. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
22. Foy, T. M., F. H. Durie, and R. J. Noelle. 1994. The expansive role of CD40 and its ligand, gp39, in immunity. Semin. Immunol. 6:259.
23. Falini, B., S. Pileri, G. Pizzolo, H. Durkop, L. Flenghi, F. Stirpe, M. F. Martelli, and H. Stein. 1995. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1.
24. Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181.
25. Shi, Y. F., B. M. Sahai, and D. R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625.
26. 1o thymocytes in vivo. Science 250: 1720.
27. Spain, L. M., and L. J. Berg. 1992. Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide. J. Exp. Med. 176:213.
28. Liblau, R. S., R. Tisch, K. Shokat, X. Yang, N. Dumont, C. C. Goodnow, and H. O. McDevitt. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc. Natl. Acad. Sci. USA 93:3031.
29. Huber, B. T. 1992. Mis superantigens: how retroviruses influence the expressed T cell receptor repertoire. Semin. Immunol. 4:313.
30. Marrack, P., G. M. Winslow, Y. Choi, M. Scherer, A. Pullen, J. White, and J. W. Kappler. 1993. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol. Rev. 131:79.
31. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179:709.
32. + thymocytes. J. Immunol. 152:3254.
33. + thymocytes. J. Immunol. 149:3217.
34. Jones, L. A., D. J. Izon, J. D. Nieland, P. S. Linsley, and A. M. Kruisbeek. 1993. CD28-B7 interactions are not required for intrathymic clonal deletion. Int. Immunol. 5:503.
35. Walunas, T. L., A. I. Sperling, R. Khattri, C. B. Thompson, and J. A. Bluestone. 1996. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156:1006.
36. Caux, C., C. Massacrier, B Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
37. Giroir, B. P., T. Brown, and B. Beutler. 1992. Constitutive synthesis of tumor necrosis factor in the thymus. Proc. Natl. Acad. Sci. USA 89:4864.
38. Murphy, M., D. S. Friend, L. Pike-Nobile, and L. B. Epstein. 1992. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus: localization and overexpression in Down syndrome (trisomy 21). J. Immunol. 149:2506.
39. Deman, J., M. T. Martin, P. Delvenne, C. Humblet, J. Boniver, and M. P. Defresne. 1992. Analysis by in situ hybridization of cells expressing mRNA for tumor-necrosis factor in the developing thymus of mice. Dev. Immunol. 2:103.
40. Probert, L., J. Keffer, P. Corbella, H. Cazlaris, E. Patsavoudi, S. Stephens, E. Kaslaris, D. Kioussis, and G. Kollias. 1993. Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J. Immunol. 151:1894.
41. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
42. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. J. Palladino, and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
43. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. J. Palladino. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
44. Bigda, J., I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, J. Bigda, H. Holtmann, and D. Wallach. 1994. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:445.
45. Medvedev, A. E., A. Sundan, and T. Espevik. 1994. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol. 24:2842.
46. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
47. Lazdins, J. K., M. Grell, M. R. Walker, K. Woods-Cook, P. Scheurich, and K. Pfizenmaier. 1997. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J. Exp. Med. 185:81.
48. Weiss, T., M. Grell, B. Hessabi, S. Bourteele, G. Muller, P. Scheurich, and H. Wajant. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158:2398.
49. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
50. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
51. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.
52. Kaye, J., N. J. Vasquez, and S. M. Hedrick. 1992. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 148:3342.
53. Germain, R. N., and H. Quill. 1986. Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells. Nature 320:72.
54. Pullen, A. M., P. Marrack, and J. W. Kappler. 1988. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 335:796.
55. Lerner, E. A., L. A. Matis, C. A. J. Janeway, P. P. Jones, R. H. Schwartz, and D. B. Murphy. 1980. Monoclonal antibody against an Ir gene product? J. Exp. Med. 152:1085.
56. Traunecker, A., F. Oliveri, and K. Karjalainen. 1991. Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol. 9:109.
57. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
58. Page, D. M., L. P. Kane, T. M. Onami, and S. M. Hedrick. 1996. Cellular and biochemical requirements for thymocyte negative selection. Semin. Immunol. 8:69.
59. + thymocytes in vitro induces early aspects of positive selection, but not apoptosis. J. Immunol. 158:65.
60. Castro, J. E., J. A. Listman, B. A. Jacobson, Y. Wang, P. A. Lopez, S. Ju, P. W. Finn, and D. L. Perkins. 1996. Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617.
61. Sytwu, H. K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
62. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990.
63. Marsters, S. A., J. P. Sheridan, C. J. Donahue, R. M. Pitti, C. L. Gray, A. D. Goddard, K. D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol. 6:1669.
64. Bodmer, J.-L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, A. Wilson, L. E. French, J. Browning, H. R. MacDonald, and J. Tschopp. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6:79.
65. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94:4615.
66. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
67. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
68. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus [see comments]. Nature 372:100.
69. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74.
70. Mazda, O., Y. Watanabe, J. Gyotoku, and Y. Katsura. 1991. Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus. J. Exp. Med. 173:539.
71. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatability comples (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541.
72. Barclay, A. N., and G. Mayrhofer. 1981. Bone marrow origin of Ia-positive cells in the medulla rat thymus. Cell Tissue Res. 218:279.
73. + T cells by transgenic I-E restricted to thymic medullary epithelium. J. Immunol. 151:3954.
74. Hoffmann, M. W., W. R. Heath, D. Ruschmeyer, and J. F. Miller. 1995. Deletion of high-avidity T cells by thymic epithelium. Proc. Natl. Acad. Sci. USA 92: 9851.
75. Volkmann, A., T. Zal, and B. Stockinger. 1997. Antigen-presenting cells in the thymus that can negatively select MHC class D-restricted T cells recognizing a circulating self antigen. J. Immunol. 158:693.
76. Laufer, T. M., J. DeKoning, J. S. Markowitz, D. Lo, and L. H. Glimcher. 1996. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383:81.
77. Miyazaki, T., G. Suzuki, and K. Yamamura. 1993. The role of macrophages in antigen presentation and T cell tolerance. Int. Immunol. 5:1023.
78. Teh, H. S., H. Kishi, B. Scott, and H. Von Boehmer. 1989. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169:795.
79. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
80. + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150.
81. Carlow, D. A., N. S. van Oers, S. J. Teh, and H. S. Teh. 1992. Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions. J. Immunol. 148:1595.
82. Tanaka, Y., C. Mamalaki, B. Stockinger, and D. Kioussis. 1993. In vitro negative selection of alpha beta T cell receptor transgenic thymocytes by conditionally immortalized thymic cortical epithelial cell lines and dendritic cells. Eur. J. Immunol. 23:2614.
83. Thomas, R., and P. E. Lipsky. 1996. Dendritic cells: origin and differentiation. Stem Cells 14:196.
84. Lerner, A., L. K. Clayton, E. Mizoguchi, Y. Ghendler, W. van Ewijk, S. Koyasu, A. K. Bhan, and E. L. Reinherz. 1996. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J. 15:5876.
85. Ludviksson, B. R., B. Gray, W. Strober, and R. O. Ehrhardt. 1997. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J. Immunol. 158:104.
86. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
87. Kotzin, B. L., S. K. Babcock, and L. R. Herron. 1988. Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2-T cells of lpr mice. J. Exp. Med. 168:2221.
88. + and abnormal lpr and gld cell populations. J. Exp. Med. 170:1869.
89. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
90. + thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Eur. J. Immunol. 25:2996.
91. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, Fukuyama H, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93:2131.
92. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90:10340.
93. Zhou, T., H. Bluethmann, J. Eldridge, M. Brockhaus, K. Berry, and J. D. Mountz. 1991. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J. Immunol. 147:466.
94. Sidman, C. L., J. D. Marshall, and H. Von Boehmer. 1992. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur. J. Immunol. 22:499.
95. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
96. + T lymphocytes to peptide antigen in vivo. J. Immunol. 151:6742.
97. + T cells. J. Immunol. 154: 4915.
98. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
99. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response [see comments]. J. Exp. Med. 184:1397.
100. Trinchieri, G., M. Kobayashi, M. Rosen, R. Loudon, M. Murphy, and B. Perussia. 1986. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J. Exp. Med. 164:1206.
101. Bermudez, L. E., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006.
102. Kendall, M. D. 1990. The cell biology of cell death in the thymus. Thymus Update 53.
103. Le, P. T., H. T. Maecker, and J. E. Cook. 1995. In situ detection and characterization of apoptotic thymocytes in human thymus: expression of bcl-2 in vivo does not prevent apoptosis. J. Immunol. 154:4371.